{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T06:28:50Z","timestamp":1794119330253,"version":"4.8.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T00:00:00Z","timestamp":1744934400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T00:00:00Z","timestamp":1744934400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"2021 Shenzhen Baoan District Basic Research (Medical and Health) Project","award":["2021JD164"],"award-info":[{"award-number":["2021JD164"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-025-04113-3","type":"journal-article","created":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T13:52:31Z","timestamp":1744984351000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Calycosin ameliorates albuminuria in nephrotic syndrome by targeting Notch1\/Snail pathway"],"prefix":"10.1186","volume":"26","author":[{"given":"Xiaohong","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binghe","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linrong","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,18]]},"reference":[{"key":"4113_CR1","doi-asserted-by":"crossref","unstructured":"Blaine J, Dylewski J. Regulation of the actin cytoskeleton in podocytes. Cells, 2020:9(7).","DOI":"10.3390\/cells9071700"},{"issue":"1","key":"4113_CR2","first-page":"36","volume":"17","author":"V Mahalingasivam","year":"2018","unstructured":"Mahalingasivam V, et al. Nephrotic syndrome in adults. Acute Med. 2018;17(1):36\u201343.","journal-title":"Acute Med"},{"key":"4113_CR3","unstructured":"Jansen J et al. Human pluripotent stem cell-derived kidney organoids for personalized congenital and idiopathic nephrotic syndrome modeling. Development, 2022:149(9)."},{"issue":"12","key":"4113_CR4","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.2215\/CJN.11440919","volume":"15","author":"AS Li","year":"2020","unstructured":"Li AS, Ingham JF, Lennon R. Genetic disorders of the glomerular filtration barrier. Clin J Am Soc Nephrol. 2020;15(12):1818\u201328.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"4113_CR5","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.bbrc.2010.04.069","volume":"396","author":"J Patrakka","year":"2010","unstructured":"Patrakka J, Tryggvason K. Molecular make-up of the glomerular filtration barrier. Biochem Biophys Res Commun. 2010;396(1):164\u20139.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"4113_CR6","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41581-020-0329-y","volume":"17","author":"RW Naylor","year":"2021","unstructured":"Naylor RW, Morais M, Lennon R. Complexities of the glomerular basement membrane. Nat Rev Nephrol. 2021;17(2):112\u201327.","journal-title":"Nat Rev Nephrol"},{"issue":"5","key":"4113_CR7","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.kint.2018.04.024","volume":"94","author":"A Meyrier","year":"2018","unstructured":"Meyrier A, Niaudet P. Acute kidney injury complicating nephrotic syndrome of minimal change disease. Kidney Int. 2018;94(5):861\u20139.","journal-title":"Kidney Int"},{"issue":"1","key":"4113_CR8","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s12882-019-1337-7","volume":"20","author":"MAD Silveira","year":"2019","unstructured":"Silveira MAD, et al. Effects of Brazilian green propolis on proteinuria and renal function in patients with chronic kidney disease: a randomized, double-blind, placebo-controlled trial. BMC Nephrol. 2019;20(1):140.","journal-title":"BMC Nephrol"},{"key":"4113_CR9","doi-asserted-by":"publisher","first-page":"113953","DOI":"10.1016\/j.biopha.2022.113953","volume":"156","author":"J Chen","year":"2022","unstructured":"Chen J, et al. Ginkgolide B alleviates oxidative stress and ferroptosis by inhibiting GPX4 ubiquitination to improve diabetic nephropathy. Biomed Pharmacother. 2022;156:113953.","journal-title":"Biomed Pharmacother"},{"key":"4113_CR10","doi-asserted-by":"publisher","first-page":"154477","DOI":"10.1016\/j.phymed.2022.154477","volume":"107","author":"J Chen","year":"2022","unstructured":"Chen J, et al. Danshen injection induces autophagy in podocytes to alleviate nephrotic syndrome via the PI3K\/AKT\/mTOR pathway. Phytomedicine. 2022;107:154477.","journal-title":"Phytomedicine"},{"key":"4113_CR11","doi-asserted-by":"publisher","first-page":"970616","DOI":"10.3389\/fphar.2022.970616","volume":"13","author":"N Zhang","year":"2022","unstructured":"Zhang N, et al. Calycosin attenuates renal ischemia\/reperfusion injury by suppressing NF-\u03baB mediated inflammation via PPAR\u03b3\/EGR1 pathway. Front Pharmacol. 2022;13:970616.","journal-title":"Front Pharmacol"},{"key":"4113_CR12","doi-asserted-by":"publisher","first-page":"108897","DOI":"10.1016\/j.cbi.2019.108897","volume":"315","author":"NM Elsherbiny","year":"2020","unstructured":"Elsherbiny NM, et al. Renoprotective effect of Calycosin in high fat diet-fed\/STZ injected rats: effect on IL-33\/ST2 signaling, oxidative stress and fibrosis suppression. Chem Biol Interact. 2020;315:108897.","journal-title":"Chem Biol Interact"},{"key":"4113_CR13","doi-asserted-by":"publisher","first-page":"113758","DOI":"10.1016\/j.biopha.2022.113758","volume":"155","author":"H Yosri","year":"2022","unstructured":"Yosri H, et al. Calycosin modulates NLRP3 and TXNIP-mediated pyroptotic signaling and attenuates diabetic nephropathy progression in diabetic rats; an insight. Biomed Pharmacother. 2022;155:113758.","journal-title":"Biomed Pharmacother"},{"key":"4113_CR14","doi-asserted-by":"publisher","first-page":"154763","DOI":"10.1016\/j.phymed.2023.154763","volume":"114","author":"YN Wang","year":"2023","unstructured":"Wang YN, et al. Moshen granule ameliorates membranous nephropathy by blocking intrarenal renin-angiotensin system signalling via the Wnt1\/\u03b2-catenin pathway. Phytomedicine. 2023;114:154763.","journal-title":"Phytomedicine"},{"key":"4113_CR15","doi-asserted-by":"publisher","first-page":"775745","DOI":"10.3389\/fphar.2021.775745","volume":"12","author":"D Feng","year":"2021","unstructured":"Feng D, et al. Integrated UPLC-MS and network Pharmacology approach to explore the active components and the potential mechanism of Yiqi Huoxue Decoction for treating nephrotic syndrome. Front Pharmacol. 2021;12:775745.","journal-title":"Front Pharmacol"},{"issue":"44","key":"4113_CR16","doi-asserted-by":"publisher","first-page":"16109","DOI":"10.1074\/jbc.RA119.008966","volume":"294","author":"R Nishad","year":"2019","unstructured":"Nishad R, et al. Growth hormone induces Notch1 signaling in podocytes and contributes to proteinuria in diabetic nephropathy. J Biol Chem. 2019;294(44):16109\u201322.","journal-title":"J Biol Chem"},{"issue":"1","key":"4113_CR17","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/s41467-017-00498-4","volume":"8","author":"M Liu","year":"2017","unstructured":"Liu M, et al. Sirt6 deficiency exacerbates podocyte injury and proteinuria through targeting Notch signaling. Nat Commun. 2017;8(1):413.","journal-title":"Nat Commun"},{"key":"4113_CR18","doi-asserted-by":"publisher","first-page":"118010","DOI":"10.1016\/j.lfs.2020.118010","volume":"257","author":"Y Dou","year":"2020","unstructured":"Dou Y, et al. Baicalin alleviates adriamycin-induced focal segmental glomerulosclerosis and proteinuria by inhibiting the Notch1-Snail axis mediated podocyte EMT. Life Sci. 2020;257:118010.","journal-title":"Life Sci"},{"key":"4113_CR19","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.jep.2015.04.015","volume":"169","author":"M Yongping","year":"2015","unstructured":"Yongping M, et al. Astragaloside prevents BDL-induced liver fibrosis through Inhibition of Notch signaling activation. J Ethnopharmacol. 2015;169:200\u20139.","journal-title":"J Ethnopharmacol"},{"key":"4113_CR20","doi-asserted-by":"crossref","unstructured":"Wei W et al. Astragalus polysaccharide RAP induces macrophage phenotype polarization to M1 via the Notch signaling pathway. Molecules, 2019. 24(10).","DOI":"10.3390\/molecules24102016"},{"key":"4113_CR21","doi-asserted-by":"publisher","first-page":"915153","DOI":"10.3389\/fphar.2022.915153","volume":"13","author":"Y Feng","year":"2022","unstructured":"Feng Y, et al. Activation of TRPC6 by angII induces podocyte injury and participates in proteinuria of nephrotic syndrome. Front Pharmacol. 2022;13:915153.","journal-title":"Front Pharmacol"},{"issue":"4","key":"4113_CR22","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.jcyt.2013.08.002","volume":"16","author":"J Guo","year":"2014","unstructured":"Guo J, et al. Protective effects of mesenchymal stromal cells on adriamycin-induced minimal change nephrotic syndrome in rats and possible mechanisms. Cytotherapy. 2014;16(4):471\u201384.","journal-title":"Cytotherapy"},{"issue":"4","key":"4113_CR23","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.kint.2018.10.032","volume":"95","author":"L Zhou","year":"2019","unstructured":"Zhou L, et al. Wnt\/\u03b2-catenin links oxidative stress to podocyte injury and proteinuria. Kidney Int. 2019;95(4):830\u201345.","journal-title":"Kidney Int"},{"key":"4113_CR24","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/978-981-13-8871-2_10","volume":"1165","author":"CC Lu","year":"2019","unstructured":"Lu CC, et al. Role of podocyte injury in glomerulosclerosis. Adv Exp Med Biol. 2019;1165:195\u2013232.","journal-title":"Adv Exp Med Biol"},{"issue":"5","key":"4113_CR25","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1161\/CIRCRESAHA.120.316970","volume":"128","author":"L Li","year":"2021","unstructured":"Li L, et al. Aberrant activation of Notch1 signaling in glomerular endothelium induces albuminuria. Circ Res. 2021;128(5):602\u201318.","journal-title":"Circ Res"},{"issue":"4","key":"4113_CR26","doi-asserted-by":"publisher","first-page":"e73","DOI":"10.1159\/000209207","volume":"111","author":"T Niranjan","year":"2009","unstructured":"Niranjan T, Murea M, Susztak K. The pathogenic role of Notch activation in podocytes. Nephron Exp Nephrol. 2009;111(4):e73\u20139.","journal-title":"Nephron Exp Nephrol"},{"key":"4113_CR27","doi-asserted-by":"crossref","unstructured":"Matoba K et al. Rho-Kinase Blockade attenuates podocyte apoptosis by inhibiting the Notch signaling pathway in diabetic nephropathy. Int J Mol Sci. 2017:18(8).","DOI":"10.3390\/ijms18081795"},{"key":"4113_CR28","doi-asserted-by":"publisher","first-page":"8184314","DOI":"10.1155\/2020\/8184314","volume":"2020","author":"W Ye","year":"2020","unstructured":"Ye W, et al. LncRNA MALAT1 regulates miR-144-3p to facilitate epithelial-Mesenchymal transition of lens epithelial cells via the ROS\/NRF2\/Notch1\/Snail pathway. Oxid Med Cell Longev. 2020;2020:8184314.","journal-title":"Oxid Med Cell Longev"},{"issue":"7","key":"4113_CR29","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.4103\/jfmpc.jfmpc_403_19","volume":"8","author":"R Singh","year":"2019","unstructured":"Singh R, et al. Correlation of spot urinary protein: creatinine ratio and quantitative proteinuria in pediatric patients with nephrotic syndrome. J Family Med Prim Care. 2019;8(7):2343\u20136.","journal-title":"J Family Med Prim Care"},{"issue":"4","key":"4113_CR30","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.pop.2020.08.002","volume":"47","author":"SA Politano","year":"2020","unstructured":"Politano SA, Colbert GB, Hamiduzzaman N. Nephrotic Syndrome Prim Care. 2020;47(4):597\u2013613.","journal-title":"Nephrotic Syndrome Prim Care"},{"issue":"1","key":"4113_CR31","doi-asserted-by":"publisher","first-page":"e0227414","DOI":"10.1371\/journal.pone.0227414","volume":"15","author":"Y Fujii","year":"2020","unstructured":"Fujii Y, et al. Efficacy of a mitochondrion-targeting agent for reducing the level of urinary protein in rats with puromycin aminonucleoside-induced minimal-change nephrotic syndrome. PLoS ONE. 2020;15(1):e0227414.","journal-title":"PLoS ONE"},{"issue":"2","key":"4113_CR32","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1007\/s10142-023-01071-7","volume":"23","author":"M Qin","year":"2023","unstructured":"Qin M, Zhang T. Danggui Shaoyaosan attenuates doxorubicin induced nephrotic syndrome through regulating on PI3K\/Akt pathway. Funct Integr Genomics. 2023;23(2):148.","journal-title":"Funct Integr Genomics"},{"key":"4113_CR33","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.cca.2021.10.017","volume":"523","author":"L Zeng","year":"2021","unstructured":"Zeng L, Szeto CC. Urinary podocyte markers in kidney diseases. Clin Chim Acta. 2021;523:315\u201324.","journal-title":"Clin Chim Acta"},{"issue":"Suppl 1","key":"4113_CR34","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1159\/000481633","volume":"47","author":"P Garg","year":"2018","unstructured":"Garg P. A review of podocyte biology. Am J Nephrol. 2018;47(Suppl 1):3\u201313.","journal-title":"Am J Nephrol"},{"issue":"16","key":"4113_CR35","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.21037\/atm-21-3577","volume":"9","author":"S Zhao","year":"2021","unstructured":"Zhao S, et al. The RNA binding protein HnRNPK protects against adriamycin-induced podocyte injury. Ann Transl Med. 2021;9(16):1303.","journal-title":"Ann Transl Med"},{"key":"4113_CR36","doi-asserted-by":"crossref","unstructured":"Nishad R et al. Activation of Notch1 signaling in podocytes by glucose-derived ages contributes to proteinuria. BMJ Open Diabetes Res Care, 2020. 8(1).","DOI":"10.1136\/bmjdrc-2020-001203"},{"issue":"12","key":"4113_CR37","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1038\/s41423-019-0318-x","volume":"17","author":"Y Jin","year":"2020","unstructured":"Jin Y, et al. Jagged1-mediated myeloid Notch1 signaling activates HSF1\/Snail and controls NLRP3 inflammasome activation in liver inflammatory injury. Cell Mol Immunol. 2020;17(12):1245\u201356.","journal-title":"Cell Mol Immunol"},{"key":"4113_CR38","doi-asserted-by":"publisher","first-page":"3296","DOI":"10.1038\/ncomms4296","volume":"5","author":"E Tanaka","year":"2014","unstructured":"Tanaka E, et al. Notch2 activation ameliorates nephrosis. Nat Commun. 2014;5:3296.","journal-title":"Nat Commun"},{"issue":"12","key":"4113_CR39","doi-asserted-by":"publisher","first-page":"4099","DOI":"10.2337\/db15-0260","volume":"64","author":"MT Sweetwyne","year":"2015","unstructured":"Sweetwyne MT, et al. Notch1 and Notch2 in podocytes play differential roles during diabetic nephropathy development. Diabetes. 2015;64(12):4099\u2013111.","journal-title":"Diabetes"},{"issue":"10","key":"4113_CR40","first-page":"5592","volume":"24","author":"YS Yuan","year":"2020","unstructured":"Yuan YS, et al. MiR-201-5p alleviates lipopolysaccharide-induced renal cell dysfunction by targeting NOTCH3. Eur Rev Med Pharmacol Sci. 2020;24(10):5592\u2013603.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"4113_CR41","doi-asserted-by":"crossref","unstructured":"Puri RV et al. Notch4 activation aggravates NF-\u03baB-mediated inflammation in HIV-1-associated nephropathy. Dis Model Mech. 2019:12(12).","DOI":"10.1242\/dmm.040642"},{"issue":"19","key":"4113_CR42","doi-asserted-by":"publisher","first-page":"11084","DOI":"10.1111\/jcmm.15514","volume":"24","author":"R Hu","year":"2020","unstructured":"Hu R, et al. Calycosin inhibited autophagy and oxidative stress in chronic kidney disease skeletal muscle atrophy by regulating AMPK\/SKP2\/CARM1 signalling pathway. J Cell Mol Med. 2020;24(19):11084\u201399.","journal-title":"J Cell Mol Med"},{"issue":"2","key":"4113_CR43","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jphs.2022.12.001","volume":"151","author":"Q Hu","year":"2023","unstructured":"Hu Q, et al. Calycosin pretreatment enhanced the therapeutic efficacy of mesenchymal stem cells to alleviate unilateral ureteral obstruction-induced renal fibrosis by inhibiting necroptosis. J Pharmacol Sci. 2023;151(2):72\u201383.","journal-title":"J Pharmacol Sci"},{"key":"4113_CR44","doi-asserted-by":"publisher","first-page":"111833","DOI":"10.1016\/j.biopha.2021.111833","volume":"141","author":"HW Zhang","year":"2021","unstructured":"Zhang HW, et al. Application of omics- and multi-omics-based techniques for natural product target discovery. Biomed Pharmacother. 2021;141:111833.","journal-title":"Biomed Pharmacother"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04113-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-025-04113-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04113-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T13:52:34Z","timestamp":1744984354000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-025-04113-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,18]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4113"],"URL":"https:\/\/doi.org\/10.1186\/s12882-025-04113-3","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,18]]},"assertion":[{"value":"19 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Animal experiments were performed under the approval of animal ethics and supervised by the Ethics Committee of Wuhan Myhalic Biotechnology Co., Ltd (approval number: HLK-202206112; approval date: June 15, 2022). We confirm that the study is reported in accordance with ARRIVE guidelines (\n                      \n                      ).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"198"}}